Long-term Follow up of Patients With Longstanding Hip and Groin Pain
Lund LHGP
Three and Seven Year Follow-up of Patients Reported Symptoms, Function and Quality of Life in Patients With Longstanding Hip and Groin Pain Referred to Tertiary Care. A Longitudinal Study
1 other identifier
observational
58
1 country
1
Brief Summary
In this longitudinal cohort study including young to middle aged people with longstanding hip and groin pain (LHGP) referred to tertiary care, we will collect data of patient reported symptoms, function and quality of life three and seven years after the initial contact with orthopedic surgeon.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
March 28, 2018
CompletedFirst Posted
Study publicly available on registry
April 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedApril 15, 2026
February 1, 2024
6.2 years
March 28, 2018
April 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in the Copenhagen Hip and Groin Outcome Score (HAGOS)
Patient reported outcome regarding hip dysfunction, which includes six subscales; pain, symptoms, physical function in daily living, physical function in sport and recreation, participation in physical activity, and quality of life. The score for each subscale ranges from 0-100, where 0 indicates extreme problems and 100 no problems. Patient Acceptable Symptom State (PASS) will be derived from HAGOS score using previously described cut-off values for the different subscales
3 and 7 years after baseline (cross-sectional study)
Secondary Outcomes (6)
HSAS - Hip Sports Activity Scale (HSAS)
3 and 7 years after baseline (cross-sectional study)
K-10 questionnaire
3 years after baseline (cross-sectional study)
Self-Presentation in Exercise Questionnaire (SPEQ)
3 years after baseline (cross-sectional study)
The Multidimensional Scale of Perceived Social Support (MSPSS)
3 years after baseline (cross-sectional study)
Medical Outcomes Study short form 36 (SF-36)
3 and 7 years after baseline (cross-sectional study)
- +1 more secondary outcomes
Other Outcomes (1)
Imaging
7 years after baseline
Eligibility Criteria
Patients will be recruited from the Department of Orthopedics, Skåne University Hospital, Sweden.
You may not qualify if:
- Unilateral or bilateral hip/groin pain \>3 months
- Age 18-55 years
- No previous hip surgery
- Hip pathology (i.e., Perthes' disease)
- Verified moderate or severe osteoarthritis (OA) (Tönnis grade \>1)
- Palpable hernia
- Low-back pain with a positive Lasègue test
- MRI-verified lower back/spine pathology (i.e., spinal stenosis, disc herniation)
- Other musculoskeletal co-morbidities overriding the hip-related symptoms and dysfunction
- Co-morbidities excluding physical activity and training
- Psycho-social disorders
- Drug abuse
- Not understanding the language of interest.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lund Universitylead
Study Sites (1)
Department of Health Sciences, Lund University
Lund, 22100, Sweden
Study Officials
- PRINCIPAL INVESTIGATOR
Eva Ageberg, PhD
Lund University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 28, 2018
First Posted
April 6, 2018
Study Start
January 1, 2018
Primary Completion
March 1, 2024
Study Completion
December 31, 2024
Last Updated
April 15, 2026
Record last verified: 2024-02